Prothena Corp Adds Director, Files 8-K
Ticker: PRTA · Form: 8-K · Filed: May 16, 2025 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, corporate-governance
Related Tickers: PRTA
TL;DR
Prothena adds Dr. Genevieve Nelson to the board, effective May 13, 2025.
AI Summary
Prothena Corporation plc announced on May 13, 2025, the election of Dr. Genevieve Nelson to its Board of Directors, effective immediately. Dr. Nelson brings extensive experience in drug development and commercialization. The company also reported on the submission of matters to a vote of security holders and filed financial statements and exhibits.
Why It Matters
The addition of a new director with relevant expertise can signal strategic growth or a shift in focus for the company. Investors will monitor the impact of this appointment on Prothena's future development and commercialization strategies.
Risk Assessment
Risk Level: low — This filing primarily concerns board appointments and routine corporate disclosures, posing minimal immediate risk.
Key Players & Entities
- Prothena Corporation plc (company) — Registrant
- Dr. Genevieve Nelson (person) — Newly elected Director
- May 13, 2025 (date) — Effective date of director election
FAQ
Who was elected to Prothena's Board of Directors?
Dr. Genevieve Nelson was elected to Prothena's Board of Directors.
When was the election of Dr. Genevieve Nelson effective?
The election of Dr. Genevieve Nelson was effective as of May 13, 2025.
What type of company is Prothena Corporation?
Prothena Corporation Public Limited Company is a pharmaceutical preparations company.
What is the SIC code for Prothena Corporation?
The Standard Industrial Classification (SIC) code for Prothena Corporation is 2834, Pharmaceutical Preparations.
What other items were reported in this 8-K filing?
This 8-K filing also reported on the submission of matters to a vote of security holders and the filing of financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 by Dr. Genevieve Nelson regarding PROTHENA CORP PUBLIC LTD CO (PRTA).